Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mie Grunnet"'
Publikováno v:
Case Reports in Pathology, Vol 2014 (2014)
Primary squamous cholangiocellular carcinomas are very rare. We describe a case of a 67-year-old man, who underwent chemotherapy and surgery for a right-sided liver tumor with an unusual presentation of metastasis to a lymph node in the left armpit.
Externí odkaz:
https://doaj.org/article/48bd0e59de2a433c8cf054e415d050bc
Autor:
Jesper B. Andersen, Julia S. Johansen, Xin W. Wang, Mogens K. Boisen, Dorte Linnemann, Douglas V.N.P. Oliveira, Morten Mau-Sørensen, Mie Grunnet, Valentina M. Factor, Hien Dang, Astrid Z. Johansen, Lars H. Jensen, Ole F. Larsen, Christian Dehlendorff, Colm J. O'Rourke, Dan Høgdall
Supplementary Figure 5: Histopathology of the HuCCT-1 xenograft tumors from control group and groups treated with gemcitabine and gemcitabine in combination with tocilizumab.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::215309a44d6104a805444d71e585d8e4
https://doi.org/10.1158/1078-0432.22477427.v1
https://doi.org/10.1158/1078-0432.22477427.v1
Autor:
Jesper B. Andersen, Julia S. Johansen, Xin W. Wang, Mogens K. Boisen, Dorte Linnemann, Douglas V.N.P. Oliveira, Morten Mau-Sørensen, Mie Grunnet, Valentina M. Factor, Hien Dang, Astrid Z. Johansen, Lars H. Jensen, Ole F. Larsen, Christian Dehlendorff, Colm J. O'Rourke, Dan Høgdall
Supplementary Figure 4: Pathway over-representation analysis of differentially expressed miRNAs across cellular compartments (parent cells, EV) and treatment groups (anti-IL6R (tocilizumab), anti-YKL40) in biliary tract cancer cells in vitro.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::142f4efc7df75bb435aa2ff333c8dfe2
https://doi.org/10.1158/1078-0432.22477430.v1
https://doi.org/10.1158/1078-0432.22477430.v1
Autor:
Jesper B. Andersen, Julia S. Johansen, Xin W. Wang, Mogens K. Boisen, Dorte Linnemann, Douglas V.N.P. Oliveira, Morten Mau-Sørensen, Mie Grunnet, Valentina M. Factor, Hien Dang, Astrid Z. Johansen, Lars H. Jensen, Ole F. Larsen, Christian Dehlendorff, Colm J. O'Rourke, Dan Høgdall
Supplementary Figure 2: Correlation of circulating biomarkers with CRP.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72ca7f6acb94916369862ca8fef8cb0f
https://doi.org/10.1158/1078-0432.22477436
https://doi.org/10.1158/1078-0432.22477436
Autor:
Jesper B. Andersen, Julia S. Johansen, Xin W. Wang, Mogens K. Boisen, Dorte Linnemann, Douglas V.N.P. Oliveira, Morten Mau-Sørensen, Mie Grunnet, Valentina M. Factor, Hien Dang, Astrid Z. Johansen, Lars H. Jensen, Ole F. Larsen, Christian Dehlendorff, Colm J. O'Rourke, Dan Høgdall
Purpose:Biliary tract cancer (BTC) is a heterogeneous group of rare gastrointestinal malignancies with dismal prognosis often associated with inflammation. We assessed the prognostic value of IL6 and YKL-40 compared with CA19-9 before and during pall
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::00423790681a630120d026d1ab3325d4
https://doi.org/10.1158/1078-0432.c.6529658.v1
https://doi.org/10.1158/1078-0432.c.6529658.v1
Autor:
Jesper B. Andersen, Julia S. Johansen, Xin W. Wang, Mogens K. Boisen, Dorte Linnemann, Douglas V.N.P. Oliveira, Morten Mau-Sørensen, Mie Grunnet, Valentina M. Factor, Hien Dang, Astrid Z. Johansen, Lars H. Jensen, Ole F. Larsen, Christian Dehlendorff, Colm J. O'Rourke, Dan Høgdall
Supplementary Figure 1: Kaplan-Meier plots depicting progression free survival (PFS) for patients with advanced biliary tract cancer as a function of pretreatment biomarker levels divided into tertiles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9337071cb57117a51ffdda92213e4509
https://doi.org/10.1158/1078-0432.22477439
https://doi.org/10.1158/1078-0432.22477439
Autor:
Jesper B. Andersen, Julia S. Johansen, Xin W. Wang, Mogens K. Boisen, Dorte Linnemann, Douglas V.N.P. Oliveira, Morten Mau-Sørensen, Mie Grunnet, Valentina M. Factor, Hien Dang, Astrid Z. Johansen, Lars H. Jensen, Ole F. Larsen, Christian Dehlendorff, Colm J. O'Rourke, Dan Høgdall
Supplementary Data, Supplementary Figure Legends, Supplementary Tables
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8b97178f30f9373234334b1aaf44c354
https://doi.org/10.1158/1078-0432.22477442
https://doi.org/10.1158/1078-0432.22477442
Autor:
Jesper B. Andersen, Julia S. Johansen, Xin W. Wang, Mogens K. Boisen, Dorte Linnemann, Douglas V.N.P. Oliveira, Morten Mau-Sørensen, Mie Grunnet, Valentina M. Factor, Hien Dang, Astrid Z. Johansen, Lars H. Jensen, Ole F. Larsen, Christian Dehlendorff, Colm J. O'Rourke, Dan Høgdall
Supplementary Figure 3: Effects of gemcitabine treatment on IL6(R) expression in vitro, impact of IL-6R and YKL-40 inhibition in BTC cell lines in vitro, expression of IL6(R) in BTC patient tumors.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91219719d059395a91437eb270b53696
https://doi.org/10.1158/1078-0432.22477433.v1
https://doi.org/10.1158/1078-0432.22477433.v1
Autor:
Xin Wei Wang, Ole Larsen, Julia S. Johansen, Colm J O'Rourke, Dan Høgdall, Jesper B. Andersen, Morten Mau-Sørensen, Mogens Karsboel Boisen, Astrid Z. Johansen, Dorte Linnemann, Hien Dang, Douglas V. N. P. Oliveira, Valentina M. Factor, Lars Henrik Jensen, Christian Dehlendorff, Mie Grunnet
Publikováno v:
Høgdall, D, O'Rourke, C J, Dehlendorff, C, Larsen, O F, Jensen, L H, Johansen, A Z, Dang, H, Factor, V M, Grunnet, M, Mau-Sørensen, M, Oliveira, D V N P, Linnemann, D, Boisen, M K, Wang, X W, Johansen, J S & Andersen, J B 2020, ' Serum IL6 as a Prognostic Biomarker and IL6R as a Therapeutic Target in Biliary Tract Cancers ', Clinical Cancer Research, vol. 26, no. 21, pp. 5655-5667 . https://doi.org/10.1158/1078-0432.CCR-19-2700
Clin Cancer Res
Clin Cancer Res
Purpose: Biliary tract cancer (BTC) is a heterogeneous group of rare gastrointestinal malignancies with dismal prognosis often associated with inflammation. We assessed the prognostic value of IL6 and YKL-40 compared with CA19-9 before and during pal
Autor:
T. Dongsgaard, Sven Tyge Langkjer, Lars Stenbygaard, Helle Lemvig Kruse, Julia Kenholm, Anne Sofie Brems-Eskildsen, Jeanette Dupont Jensen, Hella Danø, Bjørnar Gilje, Kim Wedervang, J. Neimann, Jürgen Geisler, Erik Hugger Jacobsen, Vesna Glavicic, Mie Grunnet, Annette Torbøl Brixen
Publikováno v:
Langkjer, S T, Kenholm, J, Jensen, J D, Wedervang, K, Brixen, A T, Grunnet, M, Stenbygaard, L, Gilje, B, Danø, H, Glavicic, V, Jacobsen, E H, Brems-Eskildsen, A S, Kruse, H L, Dongsgaard, T, Neimann, J & Geisler, J 2019, ' The NAME trial : A direct comparison of classical oral Navelbine versus Metronomic Navelbine in metastatic breast cancer ', Future Oncology, vol. 15, no. 22, pp. 2561-2569 . https://doi.org/10.2217/fon-2019-0124
Langkjer, S T, Kenholm, J, Jensen, J D, Wedervang, K, Brixen, A T, Grunnet, M, Stenbygaard, L, Gilje, B, Danø, H, Glavicic, V, Jacobsen, E H, Brems-Eskildsen, A S, Kruse, H L, Dongsgaard, T, Neimann, J & Geisler, J 2019, ' The NAME trial : a direct comparison of classical oral Navelbine versus metronomic Navelbine in metastatic breast cancer ', Future Oncology, vol. 15, no. 22, pp. 2561-2569 . https://doi.org/10.2217/fon-2019-0124
Langkjer, S T, Kenholm, J, Jensen, J D, Wedervang, K, Brixen, A T, Grunnet, M, Stenbygaard, L, Gilje, B, Danø, H, Glavicic, V, Jacobsen, E H, Brems-Eskildsen, A S, Kruse, H L, Dongsgaard, T, Neimann, J & Geisler, J 2019, ' The NAME trial : a direct comparison of classical oral Navelbine versus metronomic Navelbine in metastatic breast cancer ', Future Oncology, vol. 15, no. 22, pp. 2561-2569 . https://doi.org/10.2217/fon-2019-0124
Chemotherapy for metastatic breast cancer (MBC) is in general given in cycles of maximum tolerated doses to potentially maximize the therapeutic outcome. However, when compared with targeted therapies for MBC, conventional and dose intensified chemot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd3e68144dbea7113137cab419868c36
http://hdl.handle.net/10852/77735
http://hdl.handle.net/10852/77735